Thus, the loss of TP53 and RB1 pathways is a prerequisite for both the pathogenesis and lineage plasticity of NEC, but these alterations are likely to be insufficient to drive lineage reprogramming of the NEC phenotype [3, 5, 56, 64, 65]. This evidence concerns the gene TP53 and neuroendocrine carcinoma.